SG10201401305SA - Methods of predicting cancer risk using gene expression in premalignant tissue - Google Patents
Methods of predicting cancer risk using gene expression in premalignant tissueInfo
- Publication number
- SG10201401305SA SG10201401305SA SG10201401305SA SG10201401305SA SG10201401305SA SG 10201401305S A SG10201401305S A SG 10201401305SA SG 10201401305S A SG10201401305S A SG 10201401305SA SG 10201401305S A SG10201401305S A SG 10201401305SA SG 10201401305S A SG10201401305S A SG 10201401305SA
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- gene expression
- cancer risk
- predicting cancer
- premalignant tissue
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16750309P | 2009-04-07 | 2009-04-07 | |
US24370809P | 2009-09-18 | 2009-09-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201401305SA true SG10201401305SA (en) | 2014-08-28 |
Family
ID=42936861
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG2011070760A SG174611A1 (en) | 2009-04-07 | 2010-04-07 | Methods of predicting cancer risk using gene expression in premalignant tissue |
SG10201401305SA SG10201401305SA (en) | 2009-04-07 | 2010-04-07 | Methods of predicting cancer risk using gene expression in premalignant tissue |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG2011070760A SG174611A1 (en) | 2009-04-07 | 2010-04-07 | Methods of predicting cancer risk using gene expression in premalignant tissue |
Country Status (8)
Country | Link |
---|---|
US (1) | US8765383B2 (fr) |
EP (1) | EP2417271A4 (fr) |
AU (1) | AU2010234456A1 (fr) |
CA (1) | CA2757927A1 (fr) |
IL (1) | IL215253A0 (fr) |
NZ (1) | NZ595356A (fr) |
SG (2) | SG174611A1 (fr) |
WO (1) | WO2010118166A2 (fr) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2412820A1 (fr) * | 2006-01-11 | 2012-02-01 | Genomic Health, Inc. | Marqueurs de l'expression génique pour le pronostic du cancer colorectal |
US8067178B2 (en) | 2008-03-14 | 2011-11-29 | Genomic Health, Inc. | Gene expression markers for prediction of patient response to chemotherapy |
US10179936B2 (en) * | 2009-05-01 | 2019-01-15 | Genomic Health, Inc. | Gene expression profile algorithm and test for likelihood of recurrence of colorectal cancer and response to chemotherapy |
WO2012015765A2 (fr) | 2010-07-27 | 2012-02-02 | Genomic Health, Inc. | Procédé d'utilisation de l'expression génique pour déterminer le pronostic du cancer de la prostate |
DK2809810T3 (da) * | 2012-01-06 | 2020-02-03 | Viomics Inc | System og fremgangsmåde til påvisning i perifert blod af rna'er der er forandret af lungecancer |
EP3739595A3 (fr) | 2012-01-31 | 2021-01-27 | Genomic Health, Inc. | Algorithme de profil d'expression génique et test de détermination du pronostic du cancer de la prostate |
CN105143882B (zh) * | 2013-04-11 | 2018-10-26 | 塞托克尔公司 | 使用细胞学和免疫学的生物学样本评估方法 |
WO2015138889A1 (fr) * | 2014-03-13 | 2015-09-17 | The Penn State Research Foundation | Compositions et méthodes de diagnostic de stades d'endobrachyoesophage |
EP3169354A4 (fr) | 2014-07-17 | 2018-06-13 | Brian J. Czerniecki | Identification de peptides immunogènes de classe ii du complexe majeur d'histocompatibilité pour une immunothérapie |
EP3210144B1 (fr) | 2014-10-24 | 2020-10-21 | Koninklijke Philips N.V. | Pronostic médical et prédiction de réponse de traitement utilisant de activités de voies de signalisation cellulaire multiples |
AU2015334840B2 (en) | 2014-10-24 | 2021-10-21 | Innosign B.V. | Assessment of TGF-beta cellular signaling pathway activity using mathematical modelling of target gene expression |
JP7065609B6 (ja) | 2014-10-24 | 2022-06-06 | コーニンクレッカ フィリップス エヌ ヴェ | 複数の細胞シグナル伝達経路活性を用いる治療応答の医学的予後及び予測 |
ITUB20150652A1 (it) * | 2015-05-21 | 2016-11-21 | Univ Bologna Alma Mater Studiorum | Nuovo metodo diagnostico e kit |
EP3325005A4 (fr) * | 2015-07-17 | 2019-03-27 | Brian J. Czerniecki | Identification de peptides immunogènes de classe ii du complexe majeur d'histocompatibilité pour une immunothérapie |
BR112018002848A2 (pt) | 2015-08-14 | 2018-11-06 | Koninklijke Philips Nv | método, aparelho, mídia de armazenamento não transitório, programa de computador, kit para medir níveis de expressão de seis ou mais genes-alvo da via de sinalização celular |
EP3461915A1 (fr) | 2017-10-02 | 2019-04-03 | Koninklijke Philips N.V. | Évaluation de l'activité de la voie de signalisation cellulaire jak-stat1/2 faisant appel à une modélisation mathématique de l'expression du gène cible |
EP3502279A1 (fr) | 2017-12-20 | 2019-06-26 | Koninklijke Philips N.V. | Évaluation de l'activité de la voie de signalisation cellulaire mapk-ap 1 faisant appel à une modélisation mathématique de l'expression du gène cible |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6953658B2 (en) | 2000-03-09 | 2005-10-11 | Diadexus, Inc. | Method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancer |
US7622260B2 (en) | 2001-09-05 | 2009-11-24 | The Brigham And Women's Hospital, Inc. | Diagnostic and prognostic tests |
US7955800B2 (en) | 2002-06-25 | 2011-06-07 | Advpharma Inc. | Metastasis-associated gene profiling for identification of tumor tissue, subtyping, and prediction of prognosis of patients |
US20040053317A1 (en) | 2002-09-10 | 2004-03-18 | Sidney Kimmel Cancer Center | Gene segregation and biological sample classification methods |
WO2005076005A2 (fr) | 2004-01-30 | 2005-08-18 | Medizinische Universität Wien | Procede de classification d'un prelevement de cellules tumorales |
WO2006138275A2 (fr) | 2005-06-13 | 2006-12-28 | The Regents Of The University Of Michigan | Compositions et procedes de traitement et de diagnostic de cancer |
WO2006135886A2 (fr) | 2005-06-13 | 2006-12-21 | The Regents Of The University Of Michigan | Compositions et methodes pour le traitement et le diagnostic du cancer |
JP2009505658A (ja) | 2005-08-24 | 2009-02-12 | ブリストル−マイヤーズ スクイブ カンパニー | 上皮増殖因子受容体モデュレーターに対する感受性を決定するためのバイオマーカーおよび方法 |
EP2412820A1 (fr) | 2006-01-11 | 2012-02-01 | Genomic Health, Inc. | Marqueurs de l'expression génique pour le pronostic du cancer colorectal |
US7812143B2 (en) | 2006-03-31 | 2010-10-12 | Memorial Sloan-Kettering Cancer Center | Biomarkers for cancer treatment |
NZ562237A (en) | 2007-10-05 | 2011-02-25 | Pacific Edge Biotechnology Ltd | Proliferation signature and prognosis for gastrointestinal cancer |
CA2723984A1 (fr) | 2008-05-14 | 2009-11-19 | Genomic Health Inc. | Predicteurs de reponse de patient a un traitement avec des inhibiteurs des recepteurs de egf |
CN102159729B (zh) * | 2008-09-22 | 2015-07-15 | 怡发科技股份有限公司 | 肺癌及结肠直肠癌的分子标记 |
-
2010
- 2010-04-06 US US12/755,368 patent/US8765383B2/en active Active
- 2010-04-07 NZ NZ595356A patent/NZ595356A/xx unknown
- 2010-04-07 SG SG2011070760A patent/SG174611A1/en unknown
- 2010-04-07 EP EP10762395A patent/EP2417271A4/fr not_active Withdrawn
- 2010-04-07 SG SG10201401305SA patent/SG10201401305SA/en unknown
- 2010-04-07 WO PCT/US2010/030285 patent/WO2010118166A2/fr active Application Filing
- 2010-04-07 AU AU2010234456A patent/AU2010234456A1/en not_active Abandoned
- 2010-04-07 CA CA2757927A patent/CA2757927A1/fr not_active Abandoned
-
2011
- 2011-09-20 IL IL215253A patent/IL215253A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2010234456A1 (en) | 2011-10-20 |
SG174611A1 (en) | 2011-11-28 |
EP2417271A2 (fr) | 2012-02-15 |
US20100291573A1 (en) | 2010-11-18 |
CA2757927A1 (fr) | 2010-10-14 |
EP2417271A4 (fr) | 2012-08-29 |
WO2010118166A2 (fr) | 2010-10-14 |
IL215253A0 (en) | 2011-12-29 |
NZ595356A (en) | 2013-07-26 |
US8765383B2 (en) | 2014-07-01 |
WO2010118166A3 (fr) | 2011-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL215253A0 (en) | Methods of predicting cancer risk using gene expression in premalignant tissue | |
IL276487B (en) | Methods for predicting clinical outcome of cancer | |
IL280689B (en) | A method for using gene expression to determine the likelihood of clinical outcome in kidney cancer | |
IL258794B (en) | Methods and preparations for the diagnosis and treatment of cancer | |
EP2401357A4 (fr) | Cellules hôtes et procédés d'utilisation | |
IL218575A0 (en) | Treatment of cancer | |
HK1217763A1 (zh) | 用於治療疾病的方法 | |
IL216044A0 (en) | Method of expanding human hepatocytes in vivo | |
IL214255A0 (en) | Methods and compositions for diagnosis and treatment of cancer | |
EP2438197A4 (fr) | Procédé de détection du cancer | |
EP2389573A4 (fr) | Procédés d'analyse de la peau | |
EP2373794A4 (fr) | Nectine-4 pour gènes cibles de thérapie contre le cancer et de diagnostic du cancer | |
EP2398901A4 (fr) | Jarid1b en tant que gène cible d'un traitement anticancéreux et d'un diagnostic de cancer | |
EP2475790A4 (fr) | Procédés et compositions pour prédire une réponse à une thérapie anticancéreuse | |
EP2467140A4 (fr) | Procédé de traitement du cancer | |
EP2402053A4 (fr) | Sonde électro-hydraulique de traitement du tissu prostatique | |
GB0908788D0 (en) | Tissue analysis | |
EP2470903A4 (fr) | Gène et polypeptide associés au cancer du sein | |
EP2384370A4 (fr) | Utilisation de id4 pour le diagnostic et le traitement du cancer | |
GB0916686D0 (en) | Treatment of cancer | |
EP2350276A4 (fr) | Syngr4 pour gènes cibles du traitement et du diagnostic du cancer | |
EP2262541A4 (fr) | C2orf18 comme gène cible d'une thérapie et d'un diagnostic du cancer | |
TWM371583U (en) | Mashing structure of anvil block | |
GB0921757D0 (en) | Treatment of cancer | |
GB0906490D0 (en) | Use of tetanolic for treatment of breast cancer |